Actualités Apr 17, 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Aktuell Apr 30, 2024 Johnson & Johnson eröffnet Innovation Hub in Allschwil Johnson & Johnson hat im Switzerland Innovation Park Basel Area den ersten J&J Innovation Hub auf dem europäischen Festland eröffnet. Es stellt e...
Aktuell Apr 23, 2024 BGG aus China eröffnet Hauptsitz in Basel BGG richtet in Basel einen neuen globalen Hauptsitz ein und will von dort aus in Europa und den USA expandieren. Das Pekinger Unternehmen ist ein...
News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News Feb 14, 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News Jan 10, 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News Dec 22, 2023 Zynnon hits milestone in the diagnosis of respiratory infections Zynnon has reached a milestone with its technology for diagnosing viral respiratory infections. Following successful studies in hospitals, the co...
News Jun 12, 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
News Oct 25, 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News Oct 23, 2023 Valsynthèse, 40 years of innovation in the canton of Valais From dynamite to pharmaceuticals, Valsynthèse, the 'fine chemistry' business unit of the Société Suisse des Explosifs, celebrates four decades of...
News Oct 27, 2023 UZH researchers develop method for transport of large genes Researchers at the University of Zurich (UZH) have developed a new method for transporting large genes, enabling them to be transferred efficient...
News Oct 18, 2023 Cimeio collaborating with the University of Pennsylvania The Basel-based start-up Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Penns...
News Jan 26, 2022 Basel Area – exactly the right chemistry for South Korean pharma companies KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the Europe...
Aktuell Jun 28, 2023 Clear Solutions Labs will von Standort Basel profitieren Die Gründer der Clear Solutions Laboratories stellen in Basel ein Team von Fachleuten in Biotechnologie, Pharmazie und analytischer Biochemie zu...
News Jan 11, 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
News Aug 03, 2023 Worg secures financing of 130 million Swiss francs The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent ...